Following a recent patent lawsuit, SK Bioscience emerges victorious over Pfizer in the realm of pneumococcal vaccines. Looking ahead, SK Bioscience is poised to strengthen its position in the global market. In 2027, the company will introduce SKYPneumo for domestic manufacturing and sales. Moreover, a collaboration with Sanofi has led to the development of a […]